Interpreting p‐tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Jonas Goll und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, University Hospital of North Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: tau Proteins, Frailty. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, European Union's Horizon Europe research and innovation programme, Swedish State Support for Clinical Research.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
INTRODUCTION Older adults living with frailty are prone to adverse events upon acute hospitalization. Frailty biomarkers aiding early identification are lacking. This study explores frailty and Alzheimer's disease (AD)‐related biomarkers. METHODS Participants were recruited from the Norfrail study ( n = 178) and from the Norwegian Dementia Disease Initiative ( n = 105). Linear regression was used to analyze associations between frailty and the plasma biomarkers phosphorylated tau‐217 (p‐tau217), neurofilament light chain (NfL), brain‐derived tau, ubiquitin carboxyl‐terminal hydrolase L1, and glial fibrillary acidic protein in older adults admitted acutely to hospital. RESULTS No significant association was found between p‐tau217 and frailty. Estimated glomerular filtration rate (eGFR) explained 27% of the variance of plasma p‐tau217 ( p < 0.001). NfL was the only biomarker significantly associated with frailty ( p < 0.01). DISCUSSION Except for NfL, plasma biomarkers were independent of frailty. Substantial p‐tau217 variability was explained by eGFR. Clinicians need to consider renal function when interpreting p‐tau217 in unselected populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, University Hospital of North Norway, Tromsø, Norway.
- Department of Clinical Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway.
- Department of Neurology, University Hospital of North Norway, Tromsø, Norway.
- Department of Psychology, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway.
- Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Förderung
- Swedish Research Council
- European Union's Horizon Europe research and innovation programme
- Swedish State Support for Clinical Research
- Northern Norway Regional Health Authority
- University Hospital of North Norway
- Vetenskapsrådet
- Helse Nord RHF
Zitieren
APA
Goll, J., Martinaityte, I., Kirsebom, B. E., Halvorsen, D. S., Gonzalez-Ortiz, F., Zetterberg, H., Fladby, T., & Gundersen, M. D. (2026). Interpreting p‐tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71768
Vancouver
Goll J, Martinaityte I, Kirsebom BE, Halvorsen DS, Gonzalez-Ortiz F, Zetterberg H, et al. Interpreting p‐tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71768
BibTeX
@article{Goll2026,
author = {Goll, Jonas and Martinaityte, Ieva and Kirsebom, Bjørn-Eivind and Halvorsen, Dag Seeger and Gonzalez-Ortiz, Fernando and Zetterberg, Henrik and Fladby, Tormod and Gundersen, Mona Dixon},
title = {Interpreting p‐tau217 on the ward: frailty and plasma biomarkers in acutely admitted older adults},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71768}
}
EUVIMED